Abstracts Archive - Page 1687 of 2607 - ACR Meeting Abstracts

Abstract Number: 1316 • 2016 ACR/ARHP Annual Meeting
Clinical Features and Outcomes of Prosthetic Joint Septic Arthritis: The Gender Effect
Mary Louise Fowler¹, Sarah B. Lieber², Andy Moore³, Robert Shmerling⁴ and Ziv Paz², ¹Boston University School of Medicine, Boston, MA, ²Beth Israel Deaconess Medical Center, Boston, MA, ³Division of Rheumatology, Cambridge Health Alliance, Harvard Medical School, Boston, MA, ⁴Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA
Background/Purpose: In developed countries, certain health outcomes are worse among men. For example, in the US, life expectancy for men is 5 years shorter than…
Abstract Number: 1317 • 2016 ACR/ARHP Annual Meeting
Do Patients with MRSA-Positive Septic Arthritis Differ Clinically from Non-MRSA-Positive Counterparts?
Mary Louise Fowler¹, Kevin Byrne¹, Sarah B. Lieber², Andy Moore³, Robert Shmerling⁴ and Ziv Paz², ¹Boston University School of Medicine, Boston, MA, ²Beth Israel Deaconess Medical Center, Boston, MA, ³Division of Rheumatology, Cambridge Health Alliance, Harvard Medical School, Boston, MA, ⁴Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA
Do patients with MRSA-positive septic arthritis differ clinically from non-MRSA-positive counterparts? Mary Louise Fowler3, Kevin Byrne3, Sarah B. Lieber1, Andrew Moore2, Robert H. Shmerling1, Ziv…
Abstract Number: 1318 • 2016 ACR/ARHP Annual Meeting
Profile of Macrophage-Derived Cytokines and Chemokines of Patients with Chikungunya-Induced Chronic Arthralgia/Arthritis
Idali Martinez¹, Edwin Lopez¹, Zelma L. Rios¹ and Luis M. Vilá², ¹Department of Microbiology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, ²Department of Medicine, Division of Rheumatology, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico
Background/Purpose: Chikungunya virus (CHIKV) caused a large epidemic in Puerto Rico in 2014 with more than 30,000 reported cases. Many of the affected individuals developed…
Abstract Number: 1319 • 2016 ACR/ARHP Annual Meeting
Chikungunya Fever in Patients on Biological and on Conventional Dmards Therapy – Results from the Brazilian Register Biobadabrasil
Aline Ranzolin¹, Angela Duarte², Claudia Marques³, Laurindo Rocha Jr⁴, Samia Araujo de Souza Studart⁵, José Caetano Macieira⁶, Monica Valeria Siqueira S de Vechi⁶, Lina Oliveira de Carvalho⁶, Ines Guimarães da Silveira⁷, Ieda Maria Magalhães Laurindo⁸ and BiobadaBrasil, ¹Rheumatology, Instituto de Medicina Integral Professor Fernando Figueira, Recife, Brazil, ²Internal Medicine, Hospital das Clínicas - UFPE, Recife, Brazil, ³Hospital das Clínicas, Universidade Federal de Pernambuco, Recife - PE, Brazil, ⁴Rheumatology, Instituto de Medicina Integral Professor Fernando Figueira - IMIP, Recife, Brazil, ⁵Reumatologia, Hospital Geral de Fortaleza, Fortaleza, Brazil, ⁶Reumatologia, Hospital Federal de Sergipe, Aracaju, Brazil, ⁷Reumatologia, Pontificia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil, ⁸Internal Medicine - Rheumatology, Faculdade de Medicina da Universidade Nove de Julho, São Paulo, Brazil
Background/Purpose: Chikungunya fever (CHIKF) is a systemic arboviral disease manifesting with fever, acute arthritis and rash. The acute symptoms can last for days but…
Abstract Number: 1320 • 2016 ACR/ARHP Annual Meeting
Chikungunya Fever Outbreak in Brazil: Preliminary Assessment in a Cohort of Patients with Rheumatological Manifestations
Claudia Marques¹, Nara Cavalcanti², Mariana Luna³, Paula Toche², Carolina Andrade², Andrea Dantas², Aline Ranzolin², Laurindo Rocha Jr⁴, Eutília Freire⁵, Pablo Cardoso⁶, Kamila Vilar⁷, Michelly Pereira⁸, Moacyr Rêgo⁸, Maira Pitta⁶ and Angela Duarte⁹, ¹Hospital das Clínicas, Universidade Federal de Pernambuco, Recife - PE, Brazil, ²Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, Brazil, ³Universidade Federal de Pernambuco, Recife, Brazil, ⁴Rheumatology, Instituto de Medicina Integral Professor Fernando Figueira - IMIP, Recife, Brazil, ⁵Universidade Federal da Paraíba, João Pessoa, Brazil, ⁶Departamento de Bioquímica, Laboratório de Imunomodulação e Novas Abordagens Terapêuticas - UFPE, Recife, Brazil, ⁷Departamento de bioquímica, Laboratório de Imunomodulação e Novas Abordagens Terapêuticas - UFPE, Recife, Brazil, ⁸Bioquimica, Laboratório de Imunomodulação e Novas Abordagens Terapêuticas - UFPE, Recife, Brazil, ⁹Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, PE, Brazil
Background/Purpose: Chikungunya virus (CHIKV) emerged in Brazil in September 2014. Since then the infection reached epidemic proportions in the country, paticularly in the Northeast region…
Abstract Number: 1321 • 2016 ACR/ARHP Annual Meeting
Distinguishing Features of Polymicrobial Septic Arthritis
Sarah B. Lieber¹, Andy Moore², Robert Shmerling³, Mary Louise Fowler⁴ and Ziv Paz¹, ¹Beth Israel Deaconess Medical Center, Boston, MA, ²Division of Rheumatology, Cambridge Health Alliance, Harvard Medical School, Boston, MA, ³Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, ⁴Boston University School of Medicine, Boston, MA
Background/Purpose: Little is known about patients with polymicrobial septic arthritis (SA) and how they may differ from those with SA due to a single organism.…
Abstract Number: 1322 • 2016 ACR/ARHP Annual Meeting
Use of Biologics in Arthritis Patients with Hepatitis B and C ‏: A Multicentral Retrospective Case Series
Sultana Abdulaziz¹, Hessein Halabi², Mohammed Omair³, Suzan Attar⁴, Mohammed Shabrawishi⁵, Abdulwahab Neyazi⁶, Haneen Alnazzawi⁷, Noha Meraiani⁸ and Hani Almoallim⁹, ¹Dept of Medicine/Unit of Rheumatology, King Fahad Hospital, Jeddah, Saudi Arabia, ²Department of Medicine, King Faisal Specialist Hospital,, Jeddah, Saudi Arabia, ³Dept of Medicine, Div of Rheumatology, King Saud University, Riyadh, Saudi Arabia, ⁴Internal Medicine, FRCPC, ABIM, Professor in Medicine, Jeddah, Saudi Arabia, ⁵Department of Medicine, King Faisal Specialist Hospital, Jeddah, Saudi Arabia, ⁶Department of Medicine, King Abdullah Medical City, Jeddah, Saudi Arabia, ⁷King Faisal Specialist Hospital, JEDDAH, Saudi Arabia, ⁸Department of Medicine, National Guard Hospital, JEDDAH, Saudi Arabia, ⁹Department of Medicine, Umm Alqura University, Makkah, Saudi Arabia, Makkah, Saudi Arabia
Use of biologics in arthritis patients with Hepatitis B and C ‏: a multicentral retrospective case series Abstract Background/Purpose: Reactivation of viral hepatitis B…
Abstract Number: 1323 • 2016 ACR/ARHP Annual Meeting
Systemic Manifestations Associated with Parvovirus B19 Infection in Adults: A Retrospective Study in 23 Patients
Marion Dollat¹, Luc Mouthon², Gregoire Cormier³, Emilie Berthoux⁴, Alban Deroux⁵, Nathalie Costedoat-Chalumeau⁶ and François Lifermann⁷, ¹Hopital Cochin, Internal Medicine, Paris, France, ²Internal Medicine, Hopital Cochin, Paris, France, ³Rheumatology, CHD la Roche sur yon, La Roche Sur Yon, France, ⁴Centre Hospitaliser Saint Joseph Saint Luc, Lyon, Lyon, France, ⁵Internal Medicine, CHU Grenoble, Grenoble, France, ⁶Internal Medicine, Cochin University Hospital, Paris, France, ⁷CH Dax, Dax, France
Background/Purpose: Human parvovirus B19 (HPV-B19) is well known as a cause of erythema infectiosum during childhood, pure red cell aplasia in immunocompromised persons, transient aplastic…
Abstract Number: 1324 • 2016 ACR/ARHP Annual Meeting
The Result of Follow-up Interferon-Gamma-Release Assays in Patients with Rheumatic Disease Receiving Biologic Agents in a Japanese Hospital
Yasuhiro Suyama¹, Haruki Sawada², Yukihiko Ikeda³, Rui Kawato⁴, Sakura Tamaki⁴, Mitsumasa Kishimoto¹ and Masato Okada¹, ¹Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, ²Immuno-rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, ³Immune-Rheumatology center, St. Luke's International Hospital, Tokyo, Japan, ⁴Immuno rheumatology center, St. Luke's International Hospital, Tokyo, Japan
Background/Purpose: Active tuberculosis (TB) is one of the most devastating side effects of biologic agents use. Several guidelines for the prevention of biologic agents-related infections…
Abstract Number: 1325 • 2016 ACR/ARHP Annual Meeting
Musculoskeletal Manifestations in Ebola Survivors
Duane Pearson¹, Lisa Davis², John Frankhauser³ and Liron Caplan⁴, ¹Division of Rheumatology, University of Colorado, Aurora, CO, ²Div of Rheumatology, Denver Health, Denver, CO, ³Serving In Mission, Monrovia, Liberia, ⁴Div of Rheumatology, Denver VA and University of Colorado School of Medicine, Aurora, CO
Background/Purpose: Musculoskeletal complaints are common among survivors of Ebola Virus Disease (EVD) and can have clinical impacts beyond two years post-convalescence. The frequency of these…
Abstract Number: 1326 • 2016 ACR/ARHP Annual Meeting
Autoimmune Arthritides, Rheumatoid Arthritis, Psoriatic Arthritis, or Peripheral Spondyloarthropathy, Following Lyme Disease
Sheila Arvikar¹, Jameson Crowley¹, Katherine Sulka² and Allen C. Steere³, ¹Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Charlestown, MA, ²Rheumatology Allergy and Immunology, Massachusetts General Hospital, Charlestown, MA, ³Center for Immunolgy and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Lyme arthritis (LA) usually responds to antibiotic therapy, though immune-mediated synovitis may persist after antibiotic treatment, usually confined to a previously infected joint,…
Abstract Number: 1327 • 2016 ACR/ARHP Annual Meeting
Patients with Chikungunya Fever Have Increased Serum Levels of Proinflamatory Cytokines
Andrea Dantas¹, Claudia Marques², Nara Cavalcanti¹, Aline Ranzolin¹, Laurindo Rocha Jr³, Carolina Andrade¹, Paula Toche¹, Mariana Luna⁴, Kamila Vilar⁵, Pablo Cardoso⁶, Michelly Pereira⁷, Moacyr Rêgo⁷, Angela Duarte⁸ and Maira Pitta⁶, ¹Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, Brazil, ²Hospital das Clínicas, Universidade Federal de Pernambuco, Recife - PE, Brazil, ³Rheumatology, Instituto de Medicina Integral Professor Fernando Figueira - IMIP, Recife, Brazil, ⁴Universidade Federal de Pernambuco, Recife, Brazil, ⁵Departamento de bioquímica, Laboratório de Imunomodulação e Novas Abordagens Terapêuticas - UFPE, Recife, Brazil, ⁶Departamento de Bioquímica, Laboratório de Imunomodulação e Novas Abordagens Terapêuticas - UFPE, Recife, Brazil, ⁷Bioquimica, Laboratório de Imunomodulação e Novas Abordagens Terapêuticas - UFPE, Recife, Brazil, ⁸Av. Prof. Moraes Rego, s/n, Av. Prof. Moraes Rego, s/n, Recife, Brazil
Background/Purpose: Chikungunya fever (CHIK) is an arboviral disease characterized by sudden onset of fever and incapacitating polyarthralgia. Some patients develop chronic articular symptoms but the…
Abstract Number: 1328 • 2016 ACR/ARHP Annual Meeting
Infective Endocarditis with Septic Arthritis: A Single-Center Experience
Sarah B. Lieber¹, Robert Shmerling², Andy Moore³, Mary Louise Fowler⁴, Kunwal Nasrullah⁵ and Ziv Paz¹, ¹Beth Israel Deaconess Medical Center, Boston, MA, ²Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, ³Division of Rheumatology, Cambridge Health Alliance, Harvard Medical School, Boston, MA, ⁴Boston University School of Medicine, Boston, MA, ⁵Boston University Medical School, BOSTON, MA
Background/Purpose: Echocardiogram is frequently performed on patients presenting with septic arthritis (SA) but rarely demonstrates evidence of infective endocarditis (IE). Similarly, while patients with IE…
Abstract Number: 1329 • 2016 ACR/ARHP Annual Meeting
Efficacy and Safety of Biologics in Relapsing Polychondritis: A National Multicenter Study in France
Guillaume Moulis^1,2,3, Grégory Pugnet⁴, Nathalie Costedoat-Chalumeau⁵, Alexis Mathian⁶, Gaëlle Leroux⁷, Jonathan Boutemy⁸, Laurence Bouillet⁹, Sabine Berthier¹⁰, Jean Baptiste Gaultier¹¹, Pierre-Yves Jeandel¹², Amadou Konaté¹³, Arsène Mékinian¹⁴, Elisabeth Solau-Gervais¹⁵, Benjamin Terrier^16,17, Daniel Wendling¹⁸, Camille Garnier¹, Pascal Cathebras¹⁹, Laurent Arnaud²⁰, Patrice Cacoub⁷, Zahir Amoura⁶, Jean-Charles Piette⁷, Philippe Arlet²¹, Aurore Palmaro², Maryse Lapeyre-Mestre² and Laurent Sailler²², ¹Internal Medicine, Toulouse University Hospital, Toulouse, France, ²UMR 1027, INSERM-University of Toulouse, Toulouse, France, ³CIC 1436, Toiulouse, France, ⁴Department of Internal Medicine, Toulouse University Hospital, University of Toulouse, INSERM UMR 1027, Toulouse, France, ⁵Cochin University Hospital, Internal Medicine, Paris, France, ⁶Department of Internal Medicine 2. Referal center for SLE/APS, Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France, ⁷Internal Medicine, Pitié-Salpêtrière University Hospital, Paris, France, ⁸Department of Internal Medicine, Caen University Hospital, Caen, France, ⁹CHU, Grenoble, France, ¹⁰Department of Internal Medicine and Clinical Immunology, Dijon University Hospital, Dijon, France, ¹¹Internal medicine, Saint Etienne, France, ¹²Internal Medicine, Nice University Hospital, Nice, France, ¹³Internal Medicine, Montpellier University Hospital, Montpellier, France, ¹⁴Service de médecine interne. Hôpital Saint-Antoine., Paris, France, ¹⁵Rheumatology Department, University Hospital, Poitiers, Poitiers, France, ¹⁶INSERM U1016, Institut Cochin, Equipe Neutrophiles et Vascularites, Paris, France, ¹⁷National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, ¹⁸Service de Rhumatologie, CHU Jean Minjoz, Besancon, France, ¹⁹Internal Medicine, University Hospital St Etienne, St Etienne, France, ²⁰Inserm UMRS 1136, Paris, France, ²¹Service de Médecine Interne, CHU Purpan, Toulouse,, France, ²²Internal Medicine, Internal Medicine department, Toulouse University Hospital, Toulouse, France
Background/Purpose: No study has compared the efficacy and the safety of biologics in a large relapsing polychondritis (RP) cohort. This is the aim of the…
Abstract Number: 1330 • 2016 ACR/ARHP Annual Meeting
Clinical Presentations of Relapsing Polychondritis: More Than a Swollen Ear
Marcela Ferrada¹, Shubhasree D Choudhury², Kam Newman², Ninet Sinaii³, Monica Guma⁴, Thomas Christie⁵ and James D. Katz², ¹Critical Care, National Institutes of Health, Bethesda, MD, ²NIAMS, National Institutes of Health, Bethesda, MD, ³Clinical Center, National Institutes of Health, Bethesda, MD, ⁴Medicine, UCSD, La Jolla, CA, ⁵Relapsing Polychondritis Awareness and Support Foundation, Anoka, MN
Background/Purpose: Relapsing polychondritis (RP) is a rare and in some cases fatal autoimmune disease that can affect multiple organs including cartilaginous structures. The disease is…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].